- Home
- TYGO vs VTGN Comparison
TYGO vs VTGN Comparison
Compare TYGO & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYGO
- VTGN
- Stock Information
- Founded
- TYGO 2007
- VTGN 1998
- Country
- TYGO United States
- VTGN United States
- Employees
- TYGO N/A
- VTGN N/A
- Industry
- TYGO Semiconductors
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- TYGO Technology
- VTGN Health Care
- Exchange
- TYGO Nasdaq
- VTGN Nasdaq
- Market Cap
- TYGO 82.5M
- VTGN 87.2M
- IPO Year
- TYGO N/A
- VTGN N/A
- Fundamental
- Price
- TYGO $1.72
- VTGN $3.39
- Analyst Decision
- TYGO Strong Buy
- VTGN
- Analyst Count
- TYGO 1
- VTGN 0
- Target Price
- TYGO $6.00
- VTGN N/A
- AVG Volume (30 Days)
- TYGO 316.8K
- VTGN 629.8K
- Earning Date
- TYGO 11-05-2025
- VTGN 11-06-2025
- Dividend Yield
- TYGO N/A
- VTGN N/A
- EPS Growth
- TYGO N/A
- VTGN N/A
- EPS
- TYGO N/A
- VTGN N/A
- Revenue
- TYGO $74,405,000.00
- VTGN $646,000.00
- Revenue This Year
- TYGO $94.76
- VTGN $46.91
- Revenue Next Year
- TYGO $19.11
- VTGN $504.34
- P/E Ratio
- TYGO N/A
- VTGN N/A
- Revenue Growth
- TYGO 52.31
- VTGN N/A
- 52 Week Low
- TYGO $0.58
- VTGN $1.90
- 52 Week High
- TYGO $1.80
- VTGN $3.88
- Technical
- Relative Strength Index (RSI)
- TYGO 73.82
- VTGN 55.03
- Support Level
- TYGO $1.34
- VTGN $3.45
- Resistance Level
- TYGO $1.45
- VTGN $3.64
- Average True Range (ATR)
- TYGO 0.11
- VTGN 0.18
- MACD
- TYGO 0.04
- VTGN -0.01
- Stochastic Oscillator
- TYGO 89.29
- VTGN 43.68
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.